Markers of Esophageal Epithelial-Mesenchymal Transition Are Significantly Reduced in Active Eosinophilic Esophagitis Following 16 Weeks of Treatment With RPC4046, an Anti-Interleukin-13 Monoclonal Antibody

被引：1

作者：

Gann, Peter ^{[1
]}

Deaton, Ryan ^{[1
]}

McMahon, Nathan ^{[1
]}

Collins, Margaret H. ^{[2
,3
]}

Dellon, Evan S. ^{[4
]}

Hirano, Ikuo ^{[5
]}

Grimm, Michael ^{[6
]}

Woo, Amy ^{[6
]}

Karunaratne, Mahinda ^{[6
]}

Olson, Allan ^{[6
]}

Aranda, Richard ^{[6
]}

Opiteck, Gregory J. ^{[6
]}

机构：

[1] Univ Illinois, Coll Med, Dept Pathol, Chicago, IL 60612 USA

[2] Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH 45229 USA

[3] Univ Cincinnati, Coll Med, Cincinnati, OH USA

[4] Univ N Carolina, Chapel Hill, NC 27515 USA

[5] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[6] Celgene Corp, Summit, NJ USA

来源：

关键词：

D O I：

10.1016/j.jaci.2018.12.409

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

406

引用

页码：AB135 / AB135

页数：1